|
Match
|
Document |
Document Title |
|
|
US20140336131 |
METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN
Disclosed herein are methods of treating, reducing, or preventing a disease such as oral mucositis, gastric mucositis, or inflammatory fibrosis, comprising identifying a patient in need of... |
|
|
US20140323446 |
USE OF ZILEUTON FOR THE TREATMENT OF NASAL POLYPS IN CYSTIC FIBROSIS PATIENTS
The present invention provides methods of treating nasal polyps in cystic fibrosis patients using zileuton. The present invention also provides methods of treating nasal polyps in cystic fibrosis... |
|
|
US20140371134 |
Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear
In one aspect, a dry formulation for the effective administration of multiple medications simultaneously for one or more ailments may be provided. The dry formulations include one or more of the... |
|
|
US20120141608 |
SYSTEMIC ADMINISTRATION OF NAC AS AN ADJUNCT IN THE TREATMENT OF BIOTERROR EXPOSURES SUCH AS ANTHRAX, VIRUS OR RADIATION AND USE IN COMBINATION WITH DHEA FOR THE TREATMENT OF VIRUSES
The invention is for the combination and related methods of N-acetyl-cysteine oral, inhaled, or intravenous, or glutathione inhaled or intravenous, generally in combination with antibiotic and/or... |
|
|
US20140066365 |
USE OF CALIXARENES ASSOCIATED WITH AN ANTIBIOTIC IN THE TREATMENT OF BACTERIAL INFECTIONS
A product comprising at least one given antibiotic and a calixarene for use as medicament. |
|
|
US20150099726 |
DRY POWDER INHALER
This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of... |
|
|
US20120053160 |
Dosage Form for Hormonal Contraception
A dosage form for hormonal contraception containing a specific number of gestagen-containing daily units A and a specific number of gestagen-containing daily units B for uninterrupted, daily, oral... |
|
|
US20120100229 |
Treatment and Prevention of White Matter Injury with KATP Channel Activators
The present invention includes a method of treating or preventing a CNS white matter injury in a patient in need thereof. The invention also includes a method of stimulating proliferation of a CNS... |
|
|
US20120128762 |
Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders
The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to... |
|
|
US20140363511 |
METHOD OF TREATING MIDDLE EAR INFECTIONS
Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane. |
|
|
US20150231133 |
USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLUENZA, COMMON COLD AND INFLAMMATION
The embodiments described herein include methods and formulations for treating influenza, common cold and associated acute inflammation. The methods and formulations include, but are not limited... |
|
|
US20130085124 |
USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLUENZA, COMMON COLD AND INFLAMMATION
The embodiments described herein include methods and formulations for treating influenza, common cold and associated acute inflammation. The methods and formulations include, but are not limited... |
|
|
US20110250274 |
ESTRIOL FORMULATIONS
Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of estriol compounds. Embodiments described herein relate to rapidly... |
|
|
US20150071992 |
CONCENTRATED, INHALABLE ANTIBIOTIC FORMULATION
A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The... |
|
|
US20110064796 |
CONCENTRATED, INHALABLE ANTIBIOTIC FORMULATION
A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The... |
|
|
US20110178050 |
USE OF CYCLOLIGNANS FOR THE TREATMENT OF A HYPERACTIVE IMMUNE SYSTEM
There is disclosed use of certain picro derivatives of cyclolignans for prophylaxis or treatment of diseases or conditions characterised by a hyperactive immune system. Examples of cyclolignans... |
|
|
US20130289009 |
USE OF AT LEAST ONE COPRODUCT FROM THE VEGETABLE OIL REFINING INDUSTRY FOR OBTAINING A PURIFIED TOTAL UNSAPONIFIABLE VEGETABLE OIL PRODUCT
The present invention relates to the use of at least one vegetable oil refining industry by-product to obtain a purified total unsaponifiable of vegetable oil cleared of the impurities initially... |
|
|
US20150110767 |
METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION
Methods of treating, reducing, or preventing lung infections or lung inflammation include identifying a patient in need of treatment and administering a therapeutically effective amount of at... |
|
|
US20120108556 |
METHODS AND DOSAGE FORMS FOR THE TREATMENT OF HUMAN CANCERS
Methods for the treatment of human cancers, daily dosage forms for cancer patients, and methods of formulating the dosage forms are provided wherein the daily dosage form contains from about... |
|
|
US20140056999 |
TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM
The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible... |
|
|
US20120251632 |
TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM
The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible... |
|
|
US20110117213 |
TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM
The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible... |
|
|
US20150174062 |
BIODEGRADABLE DRUG DELIVERY SYSTEM
A drug delivery system (DDS) comprised of segmented biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The segmented... |
|
|
US20120263779 |
BIODEGRADABLE DRUG DELIVERY SYSTEM
A drug delivery system (DDS) comprised of segmented biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The segmented... |
|
|
US20130022661 |
BIO-REMODABLE BONE AUGMENTATION DEVICE AND METHOD
A bio-remodable augmentation device including an implantable member configured for maintaining space in a bone defect. The implantable member is formed from a bio-remodable composite having... |
|
|
US20150056277 |
DRUG DELIVERY SYSTEM
The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally... |
|
|
US20140073616 |
HYDROCORTISONE NANOTECHNOLOGICAL DELIVERY SYSTEM
A composition is provided having nano technological delivery of a medicament through the skin. The composition contains hydrocortisone, resveratrol and a sulfate free surfactant. The composition... |
|
|
US20140363425 |
SYSTEMS AND METHODS FOR IDENTIFYING CANCERS HAVING ACTIVATED PROGESTERONE RECEPTORS
Systems and methods for identifying tumors having activated progesterone receptors are provided. Patients suspected of having a tumor susceptible to growth inhibition by anti-progestins can be... |
|
|
US20140107086 |
System and Method for Diagnosis and Treatment
This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy... |
|
|
US20120201747 |
System and Method for Diagnosis and Treatment
This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy... |
|
|
US20120114716 |
Flowable Carrier Matrix
A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These... |
|
|
US20140080795 |
NRF2 Deficiency Influences Susceptibility to Steroid Resistance via HDAC2 Reduction
Methods for the treatment or prevention of diseases which are caused by the decreased concentrations of histone deacetylase 2 (HDAC2) in cells are described. The diseases which may be treated by... |
|
|
US20110288059 |
NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder in a subject. Also provided are methods for ameliorating at least one physical symptom or at least one psychological... |
|
|
US20130034500 |
Cationic Steroid Antimicrobial Compositions and Methods of Use
The invention provides methods for decreasing or inhibiting herpesviridae (HV) infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with a... |
|
|
US20150024074 |
METHODS FOR TREATING SKIN BARRIER AND REDUCING ACNE
A method of treating acne by applying to the skin an extract of Malva neglecta topically to the area of skin affected by acne to increase ceramide production at the area of skin affected by acne... |
|
|
US20140200202 |
USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE
The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3,15α,16α,17β-tetrol), namely in a method of emergency contraception. The method of... |
|
|
US20130310351 |
Treating Long QT Syndrome
This document relates to compounds useful for treating cardiac arrhythmias, for example, long QT syndrome. Also provided herein are methods and materials for using such compounds to shorten... |
|
|
US20110015134 |
Method of treatment for early stage cancer
This patent describes a method and materials to treat cancer diagnosed at an early stage, particularly breast cancer. It considers that metastatic breast cancer growth includes periods of... |
|
|
US20140045803 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic... |
|
|
US20110257136 |
Ophthalmic Formulations Of Cetirizine And Methods Of Use
The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic... |
|
|
US20130142882 |
METHODS AND COMPOSITIONS FOR TREATMENT, MODIFICATION AND MANAGEMENT OF BONE CANCER PAIN
The present invention provides methods and compositions for treating, preventing, modifying (reducing), or managing bone cancer pain by cyclohexenone compounds. |
|
|
US20140343022 |
Progesterone Antagonists such as CDB-4124 in the Treatment of Breast Cancer
The subject matter of the instant invention is pertinent to the field of cancer treatment. In particular, the instant invention is relevant to the treatment and or prevention of breast cancer in a... |
|
|
US20110053900 |
PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER
The subject matter of the instant invention is pertinent to the field of cancer treatment. In particular, the instant invention is relevant to the treatment and/or prevention of breast cancer in a... |
|
|
US20140341966 |
STEROID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS
Biocompatible intraocular implant systems are formulated for discontinuous or intermittent release of therapeutic levels of a therapeutic agent (such as a steroid) to minimize development of side... |
|
|
US20120046257 |
Methods for Administration and Formulations for the Treatment of Regional Adipose Tissue
Provided herein are pharmaceutical formulations, methods, and systems for treating regional fat deposits and fat-related conditions and indications. Methods comprise administering a pharmaceutical... |
|
|
US20110130373 |
METHODS FOR ADMINISTRATION AND FORMULATIONS FOR THE TREATMENT OF REGIONAL ADIPOSE TISSUE
Provided herein are pharmaceutical formulations, methods, and systems for treating regional fat deposits and fat-related conditions and indications. Methods comprise administering a pharmaceutical... |
|
|
US20110008269 |
Compositions and Methods Which Modulate G-Protein Signaling for the Treatment of Inflammatory Disorders such as Asthma and Allergic Conjunctivitis
Compositions and methods for the treatment of asthma and inflammatory ocular disorders are disclosed. |
|
|
US20130196962 |
NON-HORMONAL STEROID MODULATORS OF NF-KB FOR TREATMENT OF DISEASE
The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-κB for the treatment or... |
|
|
US20120190637 |
COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS
Therapeutics which employ a combination of an antiviral agent and an EP4 receptor agonist for the treatment of human respiratory diseases associated with viral infections are described. Viral... |
|
|
US20130310335 |
PROLONGED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS
The present invention concerns a prolonged release bioadhesive mucosal therapeutic system containing at least one active principle, with an active principle dissolution test of more than 70% over... |